Schwarz Pharma AG has received final approval from the FDA to market carbi-dopa-levodopa (Parcopa™) orally disintegrating tablets. The drug’s unique formulation dissolves rapidly in the mouth, thereby providing patients suffering from Parkinson’s disease with improved access to their medication. strattera medication In comparison with their current tablets, patients preferred Parcopa™ for several reasons associated with [...]
Schwarz Pharma AG has received final approval from the FDA to market carbi-dopa-levodopa (Parcopa™) orally disintegrating tablets. The drug’s unique formulation dissolves rapidly in the mouth, thereby providing patients suffering from Parkinson’s disease with improved access to their medication. generic prevacid In comparison with their current tablets, patients preferred Parcopa™ for several reasons associated with [...]
The FDA has approved the molecular entity rasagiline (Agilect, Azilect, Teva Pharmaceuticals, Israel) for the treatment of Parkinson’s disease. The drug is a monoamine oxidase type-B inhibitor that blocks the breakdown of dopamine. Dopamine sends information to the parts of the brain that control movement and coordination. Parkinson’s disease is caused by the destruction of [...]
Rivastigmine tartrate (Exelon drug, Novar-tis) has been approved for patients with mild-to-moderate dementia associated with Parkinson’s disease (PD). Rivastig-mine was previously approved for the treatment of mild-to-moderate dementia of the Alzheimer’s type. Steven Galson, MD, MPH, Director of the FDA’s Center for Drug Evaluation and Research, explains that dementia associated with PD differs from dementia [...]
The new rotigotine transdermal system (Neupro, Schwarz Bioscience) is designed to treat symptoms of early Parkinson’s disease. A member of the dopamine agonist class of drugs, rotigo-tine is delivered continuously through the skin via a silicone-based patch that is replaced every 24 hours. acomplia online
